aluates Reports

$ 0.0

Automative

Opioids Drug- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Published Date: August 2025

Report Code: QYRE-Auto-39U390

Global Opioids Drug Market Insights and Forecast to 2028

BUY CHAPTERS

Opioids Drug- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Code: QYRE-Auto-39U390

Report

August 2025

Pages:127

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

TEVA

Purdue Pharma

Mallinckrodt plc

Amneal Pharma

Collegium

J & J

Endo

Pfizer Inc

INSYS

Mylan NV

Hikma

Egalet

J & J

Opioids Drug- Market Size

The global market for Opioids Drug was estimated to be worth US$ 9694 million in 2024 and is forecast to a readjusted size of US$ 8552 million by 2031 with a CAGR of -1.8% during the forecast period 2025-2031.

Opioids Drug- Market

Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.

Global Opioids Drug main players are Purdue Pharma, Teva, Pfizer, Hikma, etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share nearly 70%.

This report aims to provide a comprehensive presentation of the global market for Opioids Drug, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Opioids Drug by region & country, by Type, and by Application.

The Opioids Drug market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opioids Drug.

Market Segmentation

Scope of Opioids Drug- Market Report

Report Metric	Details
Report Name	Opioids Drug- Market
Forecasted market size in 2031	US$ 8552 million
Forecasted years	2025 - 2031
Segment by Type	Oxycodone Hydromorphone Codeine Fentanyl
Segment by Application	Pain Relief Anesthesia Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Teva, Purdue Pharma, Mallinckrodt, Amneal Pharma, Collegium, J&J, Endo, Pfizer, INSYS, Mylan, Hikma, Egalet
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Opioids Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Opioids Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Opioids Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Opioids Drug- Market size in 2031?

Ans: The Opioids Drug- Market size in 2031 will be US$ 8552 million.

What is the market share of major companies in Opioids Drug- Market?

Ans: Global top four manufacturers hold a share over 40%.

What is the Opioids Drug- Market share by region?

Ans: North America is the largest market, with a share nearly 70%.

Who are the main players in the Opioids Drug- Market report?

Ans: The main players in the Opioids Drug- Market are Teva, Purdue Pharma, Mallinckrodt, Amneal Pharma, Collegium, J&J, Endo, Pfizer, INSYS, Mylan, Hikma, Egalet

What are the Application segmentation covered in the Opioids Drug- Market report?

Ans: The Applications covered in the Opioids Drug- Market report are Pain Relief, Anesthesia, Others

What are the Type segmentation covered in the Opioids Drug- Market report?

Ans: The Types covered in the Opioids Drug- Market report are Oxycodone, Hydromorphone, Codeine, Fentanyl

1 Market Overview

1.1 Opioids Drug Product Introduction

1.2 Global Opioids Drug Market Size Forecast

1.2.1 Global Opioids Drug Sales Value (2020-2031)

1.2.2 Global Opioids Drug Sales Volume (2020-2031)

1.2.3 Global Opioids Drug Sales Price (2020-2031)

1.3 Opioids Drug Market Trends & Drivers

1.3.1 Opioids Drug Industry Trends

1.3.2 Opioids Drug Market Drivers & Opportunity

1.3.3 Opioids Drug Market Challenges

1.3.4 Opioids Drug Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Opioids Drug Players Revenue Ranking (2024)

2.2 Global Opioids Drug Revenue by Company (2020-2025)

2.3 Global Opioids Drug Players Sales Volume Ranking (2024)

2.4 Global Opioids Drug Sales Volume by Company Players (2020-2025)

2.5 Global Opioids Drug Average Price by Company (2020-2025)

2.6 Key Manufacturers Opioids Drug Manufacturing Base and Headquarters

2.7 Key Manufacturers Opioids Drug Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Opioids Drug

2.9 Opioids Drug Market Competitive Analysis

2.9.1 Opioids Drug Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Opioids Drug Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioids Drug as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Oxycodone

3.1.2 Hydromorphone

3.1.3 Codeine

3.1.4 Fentanyl

3.2 Global Opioids Drug Sales Value by Type

3.2.1 Global Opioids Drug Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Opioids Drug Sales Value, by Type (2020-2031)

3.2.3 Global Opioids Drug Sales Value, by Type (%) (2020-2031)

3.3 Global Opioids Drug Sales Volume by Type

3.3.1 Global Opioids Drug Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Opioids Drug Sales Volume, by Type (2020-2031)

3.3.3 Global Opioids Drug Sales Volume, by Type (%) (2020-2031)

3.4 Global Opioids Drug Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Pain Relief

4.1.2 Anesthesia

4.1.3 Others

4.2 Global Opioids Drug Sales Value by Application

4.2.1 Global Opioids Drug Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Opioids Drug Sales Value, by Application (2020-2031)

4.2.3 Global Opioids Drug Sales Value, by Application (%) (2020-2031)

4.3 Global Opioids Drug Sales Volume by Application

4.3.1 Global Opioids Drug Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Opioids Drug Sales Volume, by Application (2020-2031)

4.3.3 Global Opioids Drug Sales Volume, by Application (%) (2020-2031)

4.4 Global Opioids Drug Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Opioids Drug Sales Value by Region

5.1.1 Global Opioids Drug Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Opioids Drug Sales Value by Region (2020-2025)

5.1.3 Global Opioids Drug Sales Value by Region (2026-2031)

5.1.4 Global Opioids Drug Sales Value by Region (%), (2020-2031)

5.2 Global Opioids Drug Sales Volume by Region

5.2.1 Global Opioids Drug Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Opioids Drug Sales Volume by Region (2020-2025)

5.2.3 Global Opioids Drug Sales Volume by Region (2026-2031)

5.2.4 Global Opioids Drug Sales Volume by Region (%), (2020-2031)

5.3 Global Opioids Drug Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Opioids Drug Sales Value, 2020-2031

5.4.2 North America Opioids Drug Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Opioids Drug Sales Value, 2020-2031

5.5.2 Europe Opioids Drug Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Opioids Drug Sales Value, 2020-2031

5.6.2 Asia Pacific Opioids Drug Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Opioids Drug Sales Value, 2020-2031

5.7.2 South America Opioids Drug Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Opioids Drug Sales Value, 2020-2031

5.8.2 Middle East & Africa Opioids Drug Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Opioids Drug Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Opioids Drug Sales Value

6.2.1 Key Countries/Regions Opioids Drug Sales Value, 2020-2031

6.2.2 Key Countries/Regions Opioids Drug Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Opioids Drug Sales Value, 2020-2031

6.3.2 United States Opioids Drug Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Opioids Drug Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Opioids Drug Sales Value, 2020-2031

6.4.2 Europe Opioids Drug Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Opioids Drug Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Opioids Drug Sales Value, 2020-2031

6.5.2 China Opioids Drug Sales Value by Type (%), 2024 VS 2031

6.5.3 China Opioids Drug Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Opioids Drug Sales Value, 2020-2031

6.6.2 Japan Opioids Drug Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Opioids Drug Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Opioids Drug Sales Value, 2020-2031

6.7.2 South Korea Opioids Drug Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Opioids Drug Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Opioids Drug Sales Value, 2020-2031

6.8.2 Southeast Asia Opioids Drug Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Opioids Drug Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Opioids Drug Sales Value, 2020-2031

6.9.2 India Opioids Drug Sales Value by Type (%), 2024 VS 2031

6.9.3 India Opioids Drug Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Teva

7.1.1 Teva Company Information

7.1.2 Teva Introduction and Business Overview

7.1.3 Teva Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 Teva Opioids Drug Product Offerings

7.1.5 Teva Recent Development

7.2 Purdue Pharma

7.2.1 Purdue Pharma Company Information

7.2.2 Purdue Pharma Introduction and Business Overview

7.2.3 Purdue Pharma Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 Purdue Pharma Opioids Drug Product Offerings

7.2.5 Purdue Pharma Recent Development

7.3 Mallinckrodt

7.3.1 Mallinckrodt Company Information

7.3.2 Mallinckrodt Introduction and Business Overview

7.3.3 Mallinckrodt Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Mallinckrodt Opioids Drug Product Offerings

7.3.5 Mallinckrodt Recent Development

7.4 Amneal Pharma

7.4.1 Amneal Pharma Company Information

7.4.2 Amneal Pharma Introduction and Business Overview

7.4.3 Amneal Pharma Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 Amneal Pharma Opioids Drug Product Offerings

7.4.5 Amneal Pharma Recent Development

7.5 Collegium

7.5.1 Collegium Company Information

7.5.2 Collegium Introduction and Business Overview

7.5.3 Collegium Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 Collegium Opioids Drug Product Offerings

7.5.5 Collegium Recent Development

7.6 J&J

7.6.1 J&J Company Information

7.6.2 J&J Introduction and Business Overview

7.6.3 J&J Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 J&J Opioids Drug Product Offerings

7.6.5 J&J Recent Development

7.7 Endo

7.7.1 Endo Company Information

7.7.2 Endo Introduction and Business Overview

7.7.3 Endo Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)

7.7.4 Endo Opioids Drug Product Offerings

7.7.5 Endo Recent Development

7.8 Pfizer

7.8.1 Pfizer Company Information

7.8.2 Pfizer Introduction and Business Overview

7.8.3 Pfizer Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)

7.8.4 Pfizer Opioids Drug Product Offerings

7.8.5 Pfizer Recent Development

7.9 INSYS

7.9.1 INSYS Company Information

7.9.2 INSYS Introduction and Business Overview

7.9.3 INSYS Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)

7.9.4 INSYS Opioids Drug Product Offerings

7.9.5 INSYS Recent Development

7.10 Mylan

7.10.1 Mylan Company Information

7.10.2 Mylan Introduction and Business Overview

7.10.3 Mylan Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)

7.10.4 Mylan Opioids Drug Product Offerings

7.10.5 Mylan Recent Development

7.11 Hikma

7.11.1 Hikma Company Information

7.11.2 Hikma Introduction and Business Overview

7.11.3 Hikma Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)

7.11.4 Hikma Opioids Drug Product Offerings

7.11.5 Hikma Recent Development

7.12 Egalet

7.12.1 Egalet Company Information

7.12.2 Egalet Introduction and Business Overview

7.12.3 Egalet Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)

7.12.4 Egalet Opioids Drug Product Offerings

7.12.5 Egalet Recent Development

8 Industry Chain Analysis

8.1 Opioids Drug Industrial Chain

8.2 Opioids Drug Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Opioids Drug Sales Model

8.5.2 Sales Channel

8.5.3 Opioids Drug Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

TEVA

Purdue Pharma

Mallinckrodt plc

Amneal Pharma

Collegium

J & J

Endo

Pfizer Inc

INSYS

Mylan NV

Hikma

Egalet

J & J

List of Tables

Table 1. Opioids Drug Market Trends

Table 2. Opioids Drug Market Drivers & Opportunity

Table 3. Opioids Drug Market Challenges

Table 4. Opioids Drug Market Restraints

Table 5. Global Opioids Drug Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Opioids Drug Revenue Market Share by Company (2020-2025)

Table 7. Global Opioids Drug Sales Volume by Company (2020-2025) & (M Units)

Table 8. Global Opioids Drug Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Opioids Drug Price by Company (2020-2025) & (USD/Unit)

Table 10. Key Manufacturers Opioids Drug Manufacturing Base and Headquarters

Table 11. Key Manufacturers Opioids Drug Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Opioids Drug

Table 13. Global Opioids Drug Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioids Drug as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Opioids Drug Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Opioids Drug Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Opioids Drug Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Opioids Drug Sales Market Share in Value by Type (2020-2025)

Table 20. Global Opioids Drug Sales Market Share in Value by Type (2026-2031)

Table 21. Global Opioids Drug Sales Volume by Type: 2020 VS 2024 VS 2031 (M Units)

Table 22. Global Opioids Drug Sales Volume by Type (2020-2025) & (M Units)

Table 23. Global Opioids Drug Sales Volume by Type (2026-2031) & (M Units)

Table 24. Global Opioids Drug Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Opioids Drug Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Opioids Drug Price by Type (2020-2025) & (USD/Unit)

Table 27. Global Opioids Drug Price by Type (2026-2031) & (USD/Unit)

Table 28. Global Opioids Drug Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Opioids Drug Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Opioids Drug Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Opioids Drug Sales Market Share in Value by Application (2020-2025)

Table 32. Global Opioids Drug Sales Market Share in Value by Application (2026-2031)

Table 33. Global Opioids Drug Sales Volume by Application: 2020 VS 2024 VS 2031 (M Units)

Table 34. Global Opioids Drug Sales Volume by Application (2020-2025) & (M Units)

Table 35. Global Opioids Drug Sales Volume by Application (2026-2031) & (M Units)

Table 36. Global Opioids Drug Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Opioids Drug Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Opioids Drug Price by Application (2020-2025) & (USD/Unit)

Table 39. Global Opioids Drug Price by Application (2026-2031) & (USD/Unit)

Table 40. Global Opioids Drug Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Opioids Drug Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Opioids Drug Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Opioids Drug Sales Value by Region (2020-2025) & (%)

Table 44. Global Opioids Drug Sales Value by Region (2026-2031) & (%)

Table 45. Global Opioids Drug Sales Volume by Region (M Units): 2020 VS 2024 VS 2031

Table 46. Global Opioids Drug Sales Volume by Region (2020-2025) & (M Units)

Table 47. Global Opioids Drug Sales Volume by Region (2026-2031) & (M Units)

Table 48. Global Opioids Drug Sales Volume by Region (2020-2025) & (%)

Table 49. Global Opioids Drug Sales Volume by Region (2026-2031) & (%)

Table 50. Global Opioids Drug Average Price by Region (2020-2025) & (USD/Unit)

Table 51. Global Opioids Drug Average Price by Region (2026-2031) & (USD/Unit)

Table 52. Key Countries/Regions Opioids Drug Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Opioids Drug Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Opioids Drug Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Opioids Drug Sales Volume, (2020-2025) & (M Units)

Table 56. Key Countries/Regions Opioids Drug Sales Volume, (2026-2031) & (M Units)

Table 57. Teva Company Information

Table 58. Teva Introduction and Business Overview

Table 59. Teva Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 60. Teva Opioids Drug Product Offerings

Table 61. Teva Recent Development

Table 62. Purdue Pharma Company Information

Table 63. Purdue Pharma Introduction and Business Overview

Table 64. Purdue Pharma Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 65. Purdue Pharma Opioids Drug Product Offerings

Table 66. Purdue Pharma Recent Development

Table 67. Mallinckrodt Company Information

Table 68. Mallinckrodt Introduction and Business Overview

Table 69. Mallinckrodt Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 70. Mallinckrodt Opioids Drug Product Offerings

Table 71. Mallinckrodt Recent Development

Table 72. Amneal Pharma Company Information

Table 73. Amneal Pharma Introduction and Business Overview

Table 74. Amneal Pharma Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 75. Amneal Pharma Opioids Drug Product Offerings

Table 76. Amneal Pharma Recent Development

Table 77. Collegium Company Information

Table 78. Collegium Introduction and Business Overview

Table 79. Collegium Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 80. Collegium Opioids Drug Product Offerings

Table 81. Collegium Recent Development

Table 82. J&J Company Information

Table 83. J&J Introduction and Business Overview

Table 84. J&J Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 85. J&J Opioids Drug Product Offerings

Table 86. J&J Recent Development

Table 87. Endo Company Information

Table 88. Endo Introduction and Business Overview

Table 89. Endo Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 90. Endo Opioids Drug Product Offerings

Table 91. Endo Recent Development

Table 92. Pfizer Company Information

Table 93. Pfizer Introduction and Business Overview

Table 94. Pfizer Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 95. Pfizer Opioids Drug Product Offerings

Table 96. Pfizer Recent Development

Table 97. INSYS Company Information

Table 98. INSYS Introduction and Business Overview

Table 99. INSYS Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 100. INSYS Opioids Drug Product Offerings

Table 101. INSYS Recent Development

Table 102. Mylan Company Information

Table 103. Mylan Introduction and Business Overview

Table 104. Mylan Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 105. Mylan Opioids Drug Product Offerings

Table 106. Mylan Recent Development

Table 107. Hikma Company Information

Table 108. Hikma Introduction and Business Overview

Table 109. Hikma Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 110. Hikma Opioids Drug Product Offerings

Table 111. Hikma Recent Development

Table 112. Egalet Company Information

Table 113. Egalet Introduction and Business Overview

Table 114. Egalet Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 115. Egalet Opioids Drug Product Offerings

Table 116. Egalet Recent Development

Table 117. Key Raw Materials Lists

Table 118. Raw Materials Key Suppliers Lists

Table 119. Opioids Drug Downstream Customers

Table 120. Opioids Drug Distributors List

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Opioids Drug Product Picture

Figure 2. Global Opioids Drug Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Opioids Drug Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Opioids Drug Sales Volume (2020-2031) & (M Units)

Figure 5. Global Opioids Drug Sales Price (2020-2031) & (USD/Unit)

Figure 6. Opioids Drug Report Years Considered

Figure 7. Global Opioids Drug Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Opioids Drug Players Sales Volume Ranking (2024) & (M Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Opioids Drug Revenue in 2024

Figure 10. Opioids Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. Oxycodone Picture

Figure 12. Hydromorphone Picture

Figure 13. Codeine Picture

Figure 14. Fentanyl Picture

Figure 15. Global Opioids Drug Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 16. Global Opioids Drug Sales Value Market Share by Type, 2024 & 2031

Figure 17. Global Opioids Drug Sales Volume by Type (2020 VS 2024 VS 2031) & (M Units)

Figure 18. Global Opioids Drug Sales Volume Market Share by Type, 2024 & 2031

Figure 19. Global Opioids Drug Price by Type (2020-2031) & (USD/Unit)

Figure 20. Product Picture of Pain Relief

Figure 21. Product Picture of Anesthesia

Figure 22. Product Picture of Others

Figure 23. Global Opioids Drug Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 24. Global Opioids Drug Sales Value Market Share by Application, 2024 & 2031

Figure 25. Global Opioids Drug Sales Volume by Application (2020 VS 2024 VS 2031) & (M Units)

Figure 26. Global Opioids Drug Sales Volume Market Share by Application, 2024 & 2031

Figure 27. Global Opioids Drug Price by Application (2020-2031) & (USD/Unit)

Figure 28. North America Opioids Drug Sales Value (2020-2031) & (US$ Million)

Figure 29. North America Opioids Drug Sales Value by Country (%), 2024 VS 2031

Figure 30. Europe Opioids Drug Sales Value, (2020-2031) & (US$ Million)

Figure 31. Europe Opioids Drug Sales Value by Country (%), 2024 VS 2031

Figure 32. Asia Pacific Opioids Drug Sales Value, (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Opioids Drug Sales Value by Region (%), 2024 VS 2031

Figure 34. South America Opioids Drug Sales Value, (2020-2031) & (US$ Million)

Figure 35. South America Opioids Drug Sales Value by Country (%), 2024 VS 2031

Figure 36. Middle East & Africa Opioids Drug Sales Value, (2020-2031) & (US$ Million)

Figure 37. Middle East & Africa Opioids Drug Sales Value by Country (%), 2024 VS 2031

Figure 38. Key Countries/Regions Opioids Drug Sales Value (%), (2020-2031)

Figure 39. Key Countries/Regions Opioids Drug Sales Volume (%), (2020-2031)

Figure 40. United States Opioids Drug Sales Value, (2020-2031) & (US$ Million)

Figure 41. United States Opioids Drug Sales Value by Type (%), 2024 VS 2031

Figure 42. United States Opioids Drug Sales Value by Application (%), 2024 VS 2031

Figure 43. Europe Opioids Drug Sales Value, (2020-2031) & (US$ Million)

Figure 44. Europe Opioids Drug Sales Value by Type (%), 2024 VS 2031

Figure 45. Europe Opioids Drug Sales Value by Application (%), 2024 VS 2031

Figure 46. China Opioids Drug Sales Value, (2020-2031) & (US$ Million)

Figure 47. China Opioids Drug Sales Value by Type (%), 2024 VS 2031

Figure 48. China Opioids Drug Sales Value by Application (%), 2024 VS 2031

Figure 49. Japan Opioids Drug Sales Value, (2020-2031) & (US$ Million)

Figure 50. Japan Opioids Drug Sales Value by Type (%), 2024 VS 2031

Figure 51. Japan Opioids Drug Sales Value by Application (%), 2024 VS 2031

Figure 52. South Korea Opioids Drug Sales Value, (2020-2031) & (US$ Million)

Figure 53. South Korea Opioids Drug Sales Value by Type (%), 2024 VS 2031

Figure 54. South Korea Opioids Drug Sales Value by Application (%), 2024 VS 2031

Figure 55. Southeast Asia Opioids Drug Sales Value, (2020-2031) & (US$ Million)

Figure 56. Southeast Asia Opioids Drug Sales Value by Type (%), 2024 VS 2031

Figure 57. Southeast Asia Opioids Drug Sales Value by Application (%), 2024 VS 2031

Figure 58. India Opioids Drug Sales Value, (2020-2031) & (US$ Million)

Figure 59. India Opioids Drug Sales Value by Type (%), 2024 VS 2031

Figure 60. India Opioids Drug Sales Value by Application (%), 2024 VS 2031

Figure 61. Opioids Drug Industrial Chain

Figure 62. Opioids Drug Manufacturing Cost Structure

Figure 63. Channels of Distribution (Direct Sales, and Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Opioid Drugs Market Insights Forecast to 2030

Pain Management Product Market

Global Opioid Narcotics Market Research Report 2024

Narcotic Opioid Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Opioids Agonist Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Synthetic Opioids Market Research Report 2024

Global Opioid Use Disorder Market Insights Forecast to 2030

Global Prescription Pain Medications Market Research Report 2025

Opioid Receptor Agonist Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oxycodone Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Painkiller Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Codeine Narcotic Market Research Report 2025

Global Over the Counter Pain Medication Market Research Report 2024

Global Non Opioid Pain Relief Device Market Research Report 2024

Opioid Induced Side Effects Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Lower Back Pain Drug Market Research Report 2025

Codeine Painkillers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Narcotic Analgesics Market Research Report 2025

Global OTC Pain Medications Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions